全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Epidemiology of Childhood Guillain Barré Syndrome in Yemen

DOI: 10.4236/oalib.1102425, PP. 1-7

Subject Areas: Public Health, Neurology

Keywords: Guillain-Barré Syndrome (GBS), Flaccid Paralysis, Governorate (Gov.), Children

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: GBS (Guillain-Barré Syndrome) is one of the most frequently seen acute polyneuropathy encountered in neurology practice and characterized by progressive motor weakness and loss of reflexes. Objective: The main objectives were to determine the incidence of Guillain-Barré Syndrome, distribution of paralysis and hospital outcome of patients within 60 days of admission. Material & methods: The records of all patients followed with flaccid paralysis to the surveillance sites in 11 through the WHO program for Acute Flaccid governorates in Yemen. From 21th September 2004 to 20th September 2013 were reviewed. Those patients suspected to be GBS were examined by a consultant neurologist and pediatric to confirm the diagnosis. At the time of admission specific form was designed to record demographic characteristics, clinical finding and presentation of paralysis. All patients follow up for 60 days. Collected data was entered to Epi info statistical method used by AFP program. Results: During the study period, 808 patients were diagnosed a GBS. Of this 483 (60%) were males and 325 (40%) were females. The age of the patients was ranged (between 1 to 15 years), most of them 457 (57%) were young children of ≤ 5 years old. The overall incidence was 2.8/100,000 population. The outcome of patients showed that 284 (35%) had residual paralysis. 469 (58%) recovered completely, 7 (1%) was lost and 48 (6%) patients died within 60 days of follow up. Conclusion: This study confirms that Guillain-Barré Syndrome is the most common causes of Acute Flaccid Paralysis in Yemen with high morbidity in children.

Cite this paper

Mujlli, H. M. , Al-kubati, A. S. , Mojali, A. M. and Abdurab, A. M. (2016). Epidemiology of Childhood Guillain Barré Syndrome in Yemen. Open Access Library Journal, 3, e2425. doi: http://dx.doi.org/10.4236/oalib.1102425.

References

[1]  Biller, J. (2012) Approach to the Patient with Acute Muscle Weakness. In: Horak, H.A., Ed., Practical Neurology, 4th Edition, 304-309.
[2]  Jacobs, B.C., Rothbarth, P.H., Vandermeche, F.G.A., et al. (1998) The Spectrum of Antecedent Infections in Guillain- Barre Syndrome. Neurology, 51, 1110-11115.
http://dx.doi.org/10.1212/WNL.51.4.1110
[3]  Guillain, G., Barré, J. and Strohl, A. (1916) Sur un syndrome de radiculo-nevrite avec hyperalbuminose du liquid cephalorachidien sans reaction cellulaire. Remarquessur les characters cliniqueetgraphique des reflexes tendinaux. Bulletins et Memories de la Societe Medicale des Hopitaux de Paris, 40, 1462-1470.
[4]  Alter, M. (1990) The Epidemiology of Guillain-Barré Syndrome. Annals of Neurology, 27, S7-S12.
http://dx.doi.org/10.1002/ana.410270704
[5]  Ouvrier, R.A., McLeod, J.G. and Pollard, J.D. (1999) Guillain Barré Syndrome. In: Ouvrier, R.A., McLeod, J.G. and Pollard, J.D., Eds., Peripheral Neuropathyin Childhood, 2nd Edition, Mac Keith Press, London, 42-54.
[6]  Yuki, N. (1997) Molecular Mimicry between Gangliosides and Lipopolysaccharides of Campylobacter jejuni Isolated from Patients with Guillain-Barré Syndrome and Miller Fisher Syndrome. The Journal of Infectious Diseases, 176, S150-S153.
http://dx.doi.org/10.1086/513800
[7]  Korinthenberg, R. and Monting, J.S. (1996) Natural History and Treatment Effects in Guillain-Barré Syndrome: A Multi-Centre Study. Archives of Disease in Childhood, 74, 281-287.
http://dx.doi.org/10.1136/adc.74.4.281
[8]  Kaplan, J.E., Katona, P., Hurwitz, E.S., et al. (1982) Guillain-Barré Syndrome in the United States, 1979-1980 and 1980-1981. Lack of an Association with Influenza Vaccination. JAMA, 248, 698-700.
http://dx.doi.org/10.1001/jama.1982.03330060038030
[9]  Shahar, E. and Leiderman, M. (2003) Outcome of Severe Guillain-Barré Syndrome in Children: Comparison between Untreated Cases versus Gamma-Globulin Therapy. Clinical Neuropharmacology, 26, 84-87.
http://dx.doi.org/10.1097/00002826-200303000-00007
[10]  Korinthenberg, R., Schessl, J., Kirschner, J. and Monting Jr., S. (2005) Intravenously Administered Immunoglobulin in the Treatment of Childhood Guillain-Barré Syndrome: Arandomized Trial. Pediatrics, 116, 8-14.
http://dx.doi.org/10.1542/peds.2004-1324
[11]  Carpo, M., Pedotti, R., Allaria, S., et al. (1999) Clinical Presentation and Outcome of Guillain-Barré and Related Syndromes in Relation to Anti-Ganglioside Antibodies. Journal of the Neurological Sciences, 168, 78-84.
http://dx.doi.org/10.1016/S0022-510X(99)00173-2
[12]  Barzegar, M., Dastgiri, S., Karegarmaher, M.H. and Varshochiani, A. (2007) Epidemiology of Childhood Guillan- Barré Syndrome in the North West of Iran. BMC Neurology, 7, 22.
http://dx.doi.org/10.1186/1471-2377-7-22
[13]  Asbury, A.K. (2000) New Concepts of Guillain-Barré Syndrome. Journal of Child Neurology, 15, 183-191.
http://dx.doi.org/10.1177/088307380001500308
[14]  Bradshaw, D.Y. and Jones Jr., H.R. (1992) Guillain-Barré Syndrome in Children: Clinical Course, Electrodiagnosis, and Prognosis. Muscle & Nerve, 15, 500-506.
http://dx.doi.org/10.1002/mus.880150415
[15]  By Mayo Clinic Staff. Diseases and Conditions Guillain-Barré Syndrome, ©1998-2015 Mayo Foundation for Medical Education and Research.
[16]  Rees, J.H., Soudain, S.E., Gregson, N.A. and Hughes, R.A.C. (1995) Campylobacter jejuni Infection and Guillain- Barré Syndrome. The New England Journal of Medicine, 333, 1374-1379.
http://dx.doi.org/10.1056/NEJM199511233332102
[17]  Kushnir, M., Klein, C., Pollak, L. and Rabey, J.M. (2008) Evolving Pattern of Guillain-Barré Syndrome in a Community Hospital in Israel. Acta Neurologica Scandinavica, 117, 347-350.
http://dx.doi.org/10.1111/j.1600-0404.2007.00949.x
[18]  Landaverde, J.M., Danovaro-Holliday, M.C., Trumbo, S.P., Pacis-Tirso, C.L. and Ruiz-Matus, C. (2010) Guillain- Barré Syndrome in Children Aged < 15 Years in Latin America and the Caribbean: Baseline Rates in the Context of the Influenza A (H1N1) Pandemic. The Journal of Infectious Diseases, 201, 746-750.
http://dx.doi.org/10.1086/650530
[19]  Hughes, R.A. and Rees, J.H. (1997) Clinical and Epidemiological Features of Guillain-Barré Syndrome. The Journal of Infectious Diseases, 176, S92-S98.
http://dx.doi.org/10.1086/513793
[20]  Molinero, M.R., Varon, D., Holden, K.R., Sladky, J.T., Molina, I.B. and Cleaves, F. (2003) Epidemiology of Childhood Guillain-Barré Syndrome as a Cause of Acute Flaccid Paralysis in Honduras: 1989-1999. Journal of Child Neurology, 18, 741-747.
http://dx.doi.org/10.1177/08830738030180110801
[21]  Koul, R., Al-Futaisi, A., Chacko, A., Fazalullah, M., Nabhani, S.A., Al-Awaidy, S., Al-Busaidy, S. and Al-Mahrooqi, S. (2008) Clinical Characteristics of Childhood Guillain-Barré Syndrome. Oman Medical Journal, 23, 158-161.
[22]  Rantala, H., Cherry, J.D., Shields, W.D. and Uhari, M. (1994) Epidemiology of Guillain-Barré Syndrome in Children: Relationship of Oral Polio Vaccine Administration to Occurrence. The Journal of Pediatrics, 124, 220-223.
http://dx.doi.org/10.1016/S0022-3476(94)70307-8
[23]  Evans, O.B. and Vedanarayanan, V. (1997) Guillain-Barré Syndrome. Pediatrics in Review, 18, 10-16.
http://dx.doi.org/10.1542/pir.18-1-10
[24]  Farkkila, M., Kinnunen, E., Hovi, T. and Livanainen, M. (1987) Nonintended Plasma Exchange Therapy in Poliomyelitis: Difficulties in the Differential Diagnosis of Paralytic Poliomyelitis and Polyradiculitis. Annals of Clinical Research, 19, 395-398.
[25]  Jones, H.R. (1996) Childhood Guillain-Barré Syndrome: Clinical Presentation, Diagnosis and Therapy. Journal of Child Neurology, 11, 4-12.
[26]  World Health Organization (1995) Field Guide for Supplementary Activities Aimed at Achieving polio Eradication. Publication WHO EPI/95.1, WHO, Geneva.
[27]  Olivé, J.M., Castillo, C., Castro, R.G. and de Quadros, C.A. (1997) Epidemiologic Study of Guillain-Barré Syndrome in Children < 15 Years of Age in Latin America. The Journal of Infectious Diseases, 175, S160-S164.
[28]  Jasem, J., Marof, K., Nawar, A., Khalaf, Y., Aswad, S., Hamdani, F., Islam, M. and Kalil, A. (2013) Guillain-Barré Syndrome as a Cause of Acute Flaccid Paralysis in Iraqi Children: A Result of 15 Years of Nation-Wide Study. BMC Neurology, 13, 195.
http://dx.doi.org/10.1186/1471-2377-13-195
[29]  McKhann, G.M., Cornblath, D.R., Griffin, J.W., et al. (1993) Acute Motor Axonal Neuropathy: A Frequent Cause of Acute Flaccid Paralysis in China. Annals of Neurology, 33, 333-342.
http://dx.doi.org/10.1002/ana.410330402

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413